COPD, frequent flare-ups, and a new kind of treatment

Mr. Robert, 67, has lived with COPD for about ten years. Here is his story.

Written by Katrina Metz, RESPIPLUS · Published November 20, 2026
A smiling nurse holding a clipboard talks with an older patient seated beside her.
Key takeaways
  • Mr. Robert, 67, has lived with COPD for about ten years. Despite triple inhaler therapy, pulmonary rehabilitation, up-to-date vaccines and an antibiotic to help prevent infections, he was still having up to three flare-ups a year.
  • His team suspected type 2 inflammation, which a blood test can show by counting eosinophils. Steroids like prednisone lower the eosinophil count, so the timing of the blood test matters.
  • Biologics are add-on maintenance treatments, given by injection under the skin. They are used together with usual treatments, not instead of them.
  • Each person is assessed one by one, and a biologic is not right for everyone. Talk to your health care team about the options that fit your situation.
Up to 3
flare-ups a year, despite triple inhaler therapy
400
eosinophil count, measured in the middle of a flare-up
0
flare-ups since starting the biologic, so far

A phone call with good news

A few months ago, my phone rang. It was my health care team.

They were calling because they hadn’t heard from me in a long time, and that was unusual. For years, they heard from me after every flare-up. This time I had nothing to report.

I hadn’t been sick.

My life with COPD

I’m 67, and I’ve lived with COPD for about ten years. My wife and I live far from the nearest hospital.

I quit smoking several years before I was diagnosed, but my disease kept progressing anyway. Over time I became very short of breath, and I started having frequent flare-ups. Most of them came from viral infections. My wife was still working, and colds came home with her, the way they do.

Doing everything we could

My health care team had already tried everything they could. I was on triple inhaler therapy. I had done pulmonary rehabilitation, my vaccines were up to date, and we had gone over hygiene and infection control at home. I was even taking an antibiotic to help prevent infections.

I was still having up to three flare-ups a year.

For my team, even one flare-up is too many. Three was not something they were willing to accept.

More than my breathing

The flare-ups were only part of it.

Little by little, I stopped exercising. I became more isolated, because I was afraid of getting sick. I felt guilty toward my wife: there were activities we used to enjoy together that I just couldn’t do anymore, and I felt I wasn’t doing my share around the house.

Finding the missing clue

For months, my health care team suspected that a specific kind of inflammation, called type 2 inflammation, was behind my flare-ups. A blood test can show it by counting eosinophils, a type of white blood cell.

The problem was timing. When a flare-up started, I did what I was supposed to do and followed my action plan at home, which included prednisone. My team explained that steroids like prednisone lower the eosinophil count. By the time I saw my team and had blood drawn, the signal they were looking for was already hidden.

In January 2026, I got so sick that I went to the emergency department in respiratory failure. I stayed in hospital for two weeks.

As my team put it, the only good thing about that hospital stay was the timing. My blood was tested in the middle of the flare-up, before any treatment started. My eosinophil count was 400, far above the level doctors look for.

After all those months, we finally had an answer, and something we could target.

Trying something new

After I left the hospital, I did three weeks of pulmonary rehabilitation. At the end of February, I started a biologic.

I’ll be honest: I was nervous at first. What is a biologic? What does it mean for me? But by then, I was ready to try anything that could make my life better and get my COPD under control.

What is a biologic?

Biologics are medications made using living organisms, such as cells grown in a laboratory, rather than from chemicals alone.

In Canada, two biologics are currently approved for COPD. Health Canada has approved them as add-on maintenance treatments for adults whose COPD is characterized by raised blood eosinophils and is not well controlled by their inhaled medications.

“Add-on” means they are used together with usual treatments, not instead of them. They are given by injection under the skin, on a schedule set by the health care team. The team checks over time whether the biologic is helping. If it isn’t, it is stopped and other options are explored.

Sources: Health Canada, Handbook for health care professionals on biosimilar biologic drugs: About biologic drugs and biosimilars; Health Canada, Drug and Health Product Portal, regulatory decision summaries for biologics approved in COPD.

More active, more confident

Which brings me back to that phone call.

Since I started the biologic, I haven’t had a flare-up so far. I even caught a cold and didn’t need to use my action plan, which had never happened before. Slowly, I’m regaining confidence that not everything is going to make me sick.

I’m not cured. I’m still short of breath. What has changed is everything around my breathing. I keep up with my exercise program, I’m more active, and I can take part in the chores at home again. The stability itself is reassuring.

I continue the biologic along with all my other treatments. My team reminds me that these treatments work together, and together they help keep me stable.

Every story is different

My health care team and I are aware that my story is a good story. Each person is assessed one by one. If a biologic doesn’t help, it is stopped, and the team keeps working on preventing flare-ups with the other treatment options they have.

Portrait of Dr. Jean Bourbeau, respirologist at McGill University.

Speaking about stories like mine, Dr. Jean Bourbeau, a respirologist at McGill University, says:

“People have to understand that it’s not possible for every patient. But it’s not an exceptional story. What is exceptional sometimes is that we wait, we wait too long.
“Early is better than late,” Dr. Bourbeau says. “Late is never too late.”

Mr. Robert’s experience is his own. Results can differ from person to person and between biologics, and a biologic is not right for everyone. Talk to your health care team about the options that fit your situation.

Questions to bring to your next appointment

If you live with COPD and still have flare-ups despite your treatment, these questions can open the conversation with your health care team:

  • How many flare-ups have I had in the past year, and is that more than we should accept?
  • Have I had a blood test for eosinophils, and was it taken before or after I took prednisone?
  • Should we look for type 2 inflammation in my case?
  • In what instances is a biologic right for me?
Portrait of Dr. Jean Bourbeau.
Dr. Jean Bourbeau
Respirologist, McGill University
Portrait of Joanie Bernier, nurse practitioner specializing in respiratory care.
Joanie Bernier
Nurse practitioner, respiratory care

To hear Dr. Jean Bourbeau, respirologist at McGill University, and Joanie Bernier, nurse practitioner specializing in respiratory care, explain these new treatments in plain language, watch our World COPD Day webinar The Next Breath: COPD’s Biologic Era, available on demand on the eXpand website.

Watch the free webinar

Free, on demand, in English and French.

Keep exploring
  1. PageWorld COPD DayEverything we published for World COPD Day 2026
  2. ProgramLiving Well with COPDThe free self-management program
  3. BlogTaking Your COPD MedicationsThe updated module on medications and inhalers

New to COPD? Start with the COPD hub for an overview of the disease and how it is managed.

Developed by RESPIPLUS with the support of an educational grant from Sanofi and Regeneron.

This content is for educational purposes only and does not replace the advice of your healthcare team. Copyright © 2026 RESPIPLUS. All rights reserved.